CPD3504
|
|
|
- CAS号:
- 2162982-11-6
- 英文名:
- BAY-218
- 英文别名:
- CPD3504;BAY-218;BAY-2335218;AHR antagonist 1;BAY-218(AHR antagonist 1);BAY2335218;BAY-2335218;BAY 2335218;BAY218;BAY 218;BAY-218;6-(4-chlorophenyl)-2-(3-fluorophenyl)-N-[(1S)-2-hydroxy-1-methyl-ethyl]-3-oxo-pyridazine-4-carboxamide;(S)-6-(4-Chlorophenyl)-2-(3-fluorophenyl)-N-(1-hydroxypropan-2-yl)-3-oxo-2，3-dihydropyridazine-4-carboxamide;6-(4-chlorophenyl)-2-(3-fluorophenyl)-N-[(2S)-1-hydroxypropan-2-yl]-3-oxo-2,3-dihydropyridazine-4-carboxamide;4-Pyridazinecarboxamide, 6-(4-chlorophenyl)-2-(3-fluorophenyl)-2,3-dihydro-N-[(1S)-2-hydroxy-1-methylethyl]-3-oxo-
- 中文名:
- CPD3504
- 中文别名:
- 化合物AHR ANTAGONIST 1;(S)-6-(4-氯苯基)-2-(3-氟苯基)-N-(1-羟基丙-2-基)-3-氧代-2,3-二氢哒嗪-4-甲酰胺
- CBNumber:
- CB44908494
- 分子式:
- C20H17ClFN3O3
- 分子量:
- 401.82
- MOL File:
- 2162982-11-6.mol
|
|
|
CPD3504化学性质
-
密度:
-
1.37±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO:80.0(Max Conc. mg/mL);199.09(Max Conc. mM)
Ethanol:20.0(Max Conc. mg/mL);49.77(Max Conc. mM)-
|
-
酸度系数(pKa):
-
11.81±0.20(Predicted)
-
|
CPD3504性质、用途与生产工艺
BAY-218是一种有效的、选择性AhR小分子抑制剂，抑制AhR核转运、DRE荧光酶报告基因的表达以及AhR调控的靶基因表达。
CPD3504
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/01/25 | HY-111449 | BAY-218 | | 1 mg | 340元 |
| 2024/01/25 | HY-111449 | CPD3504
BAY-218 | 2162982-11-6 | 5mg | 750元 |
2162982-11-6, CPD3504 相关搜索:
- 药靶配体
- 化工试剂
- 生化试剂
- 化合物AHR ANTAGONIST 1
- (S)-6-(4-氯苯基)-2-(3-氟苯基)-N-(1-羟基丙-2-基)-3-氧代-2,3-二氢哒嗪-4-甲酰胺
- 2162982-11-6
- 6-(4-chlorophenyl)-2-(3-fluorophenyl)-N-[(1S)-2-hydroxy-1-methyl-ethyl]-3-oxo-pyridazine-4-carboxamide
- cancer,human monocytic U937 cells,AHR antagonist1,inhibit,Aryl Hydrocarbon Receptor,Inhibitor,BAY218,aryl hydrocarbon receptor (AHR),U87 glioblastoma cells,AHR antagonist-1,immune,BAY 218,BAY-218,AhR
- BAY-218(AHR antagonist 1)
- (S)-6-(4-Chlorophenyl)-2-(3-fluorophenyl)-N-(1-hydroxypropan-2-yl)-3-oxo-2，3-dihydropyridazine-4-carboxamide
- 6-(4-chlorophenyl)-2-(3-fluorophenyl)-N-[(2S)-1-hydroxypropan-2-yl]-3-oxo-2,3-dihydropyridazine-4-carboxamide
- 4-Pyridazinecarboxamide, 6-(4-chlorophenyl)-2-(3-fluorophenyl)-2,3-dihydro-N-[(1S)-2-hydroxy-1-methylethyl]-3-oxo-
- AHR antagonist 1
- BAY-2335218
- CPD3504
- BAY-218
- BAY2335218;BAY-2335218;BAY 2335218;BAY218;BAY 218;BAY-218